August 13, 2020 | 1:00 PM EDT

Bloomberg Prognosis:
How Covid-19 is Reshaping the Global Healthcare Ecosystem

The Covid-19 pandemic is reshaping almost every aspect of our society, including our healthcare systems. In this global emergency, in which the coronavirus continues its inexorable spread with a disproportionate impact on communities of color, the urgent search for effective therapeutics and an effective vaccine has led to unprecedented collaborations between healthcare and drug companies, academic researchers, nonprofits and governments. Even so, some stresses to this collaborative approach are evident, such as governments eager to secure first treatments and potential vaccines for their domestic populations.

 

How will this ongoing crisis continue to shape the evolution of the clinical and research ecosystem to combat future health care challenges? How can we make systemic changes to close the gaps in access to care laid bare by the pandemic?  How are institutional investors, including VC and PE firms, deploying capital to biotech startups? How can we create greater incentives (and reduce the disincentives) to spur research to meet these needs? And looking further ahead, how can executives, researchers and policy makers take the lessons learned from the early days of this crisis to more broadly rethink approaches to health care?

August 13 - Thursday

1:00 pm

Welcome Remarks

1:02 pm

Opening Remarks

Speaker

1:05 pm

In Conversation with...

1:25 pm

Bloomberg Intelligence Presentation

Speaker

  • Sam Fazeli

    Director of Research, Bloomberg Intelligence, Bloomberg

1:35 pm

The Race to Solve the Covid-19 Crisis

Speakers

1:55 pm

The Next Health Care Threat

Speakers

  • Neil Ferguson

    Founding Director, MRC Centre for Global Infectious Disease Analysis, Imperial College London

  • Devi Sridhar

    Founding Director, Global Health Governance Programme, Professor, University of Edinburgh Medical School

  • Soumya Swaminathan

    Chief Scientist, World Health Organization

Moderator

Speakers

Neil Ferguson

Founding Director, MRC Centre for Global Infectious Disease Analysis Imperial College London

Devi Sridhar

Founding Director, Global Health Governance Programme Professor, University of Edinburgh Medical School

Soumya Swaminathan

Chief Scientist World Health Organization

Stephen Ubl

President & Chief Executive Officer PhRMA

John Fraher

Senior Executive Editor Bloomberg

Sam Fazeli

Director of Research, Bloomberg Intelligence Bloomberg

Dr Seth Berkley

CEO Gavi, The Vaccine Alliance

Sponsor

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures, including an estimated $79.6 billion in 2018 alone.